Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Drug Integrated Polymer Fibers Market by Type (Polylactic Acid, Polydioxanone, Polycaprolactone), By Application (Drug Delivery, Orthopaedic Sutures, Vascular Stents, Vascular Grafts, Dermal Wound Healing) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Drug Integrated Polymer Fibers Market by Type (Polylactic Acid, Polydioxanone, Polycaprolactone), By Application (Drug Delivery, Orthopaedic Sutures, Vascular Stents, Vascular Grafts, Dermal Wound Healing) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 188101 3300 Pharma & Healthcare 377 246 Pages 4.7 (30)
                                          

The global drug integrated polymer fibers market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 1.2 billion by 2030. The growth of this market is driven by the increasing demand for biodegradable and eco-friendly materials in medical applications, such as drug delivery, orthopaedic sutures, vascular stents and vascular grafts. Polylactic acid (PLA) is one of the most commonly used polymers in medical applications due to its biocompatibility and low cost. Polycaprolactone (PCL) has also been gaining traction due to its high mechanical strength and low cost compared with other polymers such as PLA or PLLA. Polylactic acid dominated the global drug integrated polymer fibers market in 2017 with a share of over 50%. This can be attributed to its wide range of properties that make it suitable for various applications including drug delivery, orthopaedic sutures, vascular stents and vascular grafts among others. Polydioxanone (PDO) was the second largest segment in 2017 with a share of over 30%. PDO has been gaining traction due to its high tensile strength which makes it suitable for use as an alternative material for surgical sutures or ligatures that are used on internal organs or tissues where there is no risk of infection from foreign materials entering through open wounds during surgery.

  1. The increasing demand for high-quality and comfortable clothing is one of the major factors driving the growth of this market.
  2. The increasing disposable income in developing countries such as China, India, and Brazil is also driving the growth of this market.
  3. Increasing awareness about health benefits associated with wearing natural fibers such as cotton and wool are also driving the growth of this market.
  4. Increasing demand for eco-friendly clothing due to environmental concerns is another factor that will drive the growth of this market.

Industry Growth Insights published a new data on “Drug Integrated Polymer Fibers Market”. The research report is titled “Drug Integrated Polymer Fibers Market research by Types (Polylactic Acid, Polydioxanone, Polycaprolactone), By Applications (Drug Delivery, Orthopaedic Sutures, Vascular Stents, Vascular Grafts, Dermal Wound Healing), By Players/Companies TissueGen, Micro Engineering Solutions, Integrated Polymer Solutions”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Drug Integrated Polymer Fibers Market Research Report

By Type

Polylactic Acid, Polydioxanone, Polycaprolactone

By Application

Drug Delivery, Orthopaedic Sutures, Vascular Stents, Vascular Grafts, Dermal Wound Healing

By Companies

TissueGen, Micro Engineering Solutions, Integrated Polymer Solutions

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

246

Number of Tables & Figures

173

Customization Available

Yes, the report can be customized as per your need.


Global Drug Integrated Polymer Fibers Industry Outlook


Global Drug Integrated Polymer Fibers Market Report Segments:

The global Drug Integrated Polymer Fibers market is segmented on the basis of:

Types

Polylactic Acid, Polydioxanone, Polycaprolactone

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Drug Delivery, Orthopaedic Sutures, Vascular Stents, Vascular Grafts, Dermal Wound Healing

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. TissueGen
  2. Micro Engineering Solutions
  3. Integrated Polymer Solutions

Global Drug Integrated Polymer Fibers Market Overview


Highlights of The Drug Integrated Polymer Fibers Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Polylactic Acid
    2. Polydioxanone
    3. Polycaprolactone
  1. By Application:

    1. Drug Delivery
    2. Orthopaedic Sutures
    3. Vascular Stents
    4. Vascular Grafts
    5. Dermal Wound Healing
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Drug Integrated Polymer Fibers Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Drug Integrated Polymer Fibers Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Drug Integrated Polymer Fibers are a type of polymer fiber that is specifically designed to be inserted into drug delivery systems. This allows for improved patient safety and faster drug delivery times.

Some of the major players in the drug integrated polymer fibers market are TissueGen, Micro Engineering Solutions, Integrated Polymer Solutions.

The drug integrated polymer fibers market is expected to grow at a compound annual growth rate of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Drug Integrated Polymer Fibers Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Drug Integrated Polymer Fibers Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Drug Integrated Polymer Fibers Market - Supply Chain
   4.5. Global Drug Integrated Polymer Fibers Market Forecast
      4.5.1. Drug Integrated Polymer Fibers Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Drug Integrated Polymer Fibers Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Drug Integrated Polymer Fibers Market Absolute $ Opportunity

5. Global Drug Integrated Polymer Fibers Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Drug Integrated Polymer Fibers Market Size and Volume Forecast by Type
      5.3.1. Polylactic Acid
      5.3.2. Polydioxanone
      5.3.3. Polycaprolactone
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Drug Integrated Polymer Fibers Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Drug Integrated Polymer Fibers Market Size and Volume Forecast by Application
      6.3.1. Drug Delivery
      6.3.2. Orthopaedic Sutures
      6.3.3. Vascular Stents
      6.3.4. Vascular Grafts
      6.3.5. Dermal Wound Healing
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Drug Integrated Polymer Fibers Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Drug Integrated Polymer Fibers Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Drug Integrated Polymer Fibers Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Drug Integrated Polymer Fibers Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Drug Integrated Polymer Fibers Demand Share Forecast, 2019-2026

9. North America Drug Integrated Polymer Fibers Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Drug Integrated Polymer Fibers Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Drug Integrated Polymer Fibers Market Size and Volume Forecast by Application
      9.4.1. Drug Delivery
      9.4.2. Orthopaedic Sutures
      9.4.3. Vascular Stents
      9.4.4. Vascular Grafts
      9.4.5. Dermal Wound Healing
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Drug Integrated Polymer Fibers Market Size and Volume Forecast by Type
      9.7.1. Polylactic Acid
      9.7.2. Polydioxanone
      9.7.3. Polycaprolactone
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Drug Integrated Polymer Fibers Demand Share Forecast, 2019-2026

10. Latin America Drug Integrated Polymer Fibers Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Drug Integrated Polymer Fibers Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Drug Integrated Polymer Fibers Market Size and Volume Forecast by Application
      10.4.1. Drug Delivery
      10.4.2. Orthopaedic Sutures
      10.4.3. Vascular Stents
      10.4.4. Vascular Grafts
      10.4.5. Dermal Wound Healing
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Drug Integrated Polymer Fibers Market Size and Volume Forecast by Type
      10.7.1. Polylactic Acid
      10.7.2. Polydioxanone
      10.7.3. Polycaprolactone
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Drug Integrated Polymer Fibers Demand Share Forecast, 2019-2026

11. Europe Drug Integrated Polymer Fibers Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Drug Integrated Polymer Fibers Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Drug Integrated Polymer Fibers Market Size and Volume Forecast by Application
      11.4.1. Drug Delivery
      11.4.2. Orthopaedic Sutures
      11.4.3. Vascular Stents
      11.4.4. Vascular Grafts
      11.4.5. Dermal Wound Healing
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Drug Integrated Polymer Fibers Market Size and Volume Forecast by Type
      11.7.1. Polylactic Acid
      11.7.2. Polydioxanone
      11.7.3. Polycaprolactone
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Drug Integrated Polymer Fibers Demand Share, 2019-2026

12. Asia Pacific Drug Integrated Polymer Fibers Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Drug Integrated Polymer Fibers Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Drug Integrated Polymer Fibers Market Size and Volume Forecast by Application
      12.4.1. Drug Delivery
      12.4.2. Orthopaedic Sutures
      12.4.3. Vascular Stents
      12.4.4. Vascular Grafts
      12.4.5. Dermal Wound Healing
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Drug Integrated Polymer Fibers Market Size and Volume Forecast by Type
      12.7.1. Polylactic Acid
      12.7.2. Polydioxanone
      12.7.3. Polycaprolactone
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Drug Integrated Polymer Fibers Demand Share, 2019-2026

13. Middle East & Africa Drug Integrated Polymer Fibers Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Drug Integrated Polymer Fibers Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Drug Integrated Polymer Fibers Market Size and Volume Forecast by Application
      13.4.1. Drug Delivery
      13.4.2. Orthopaedic Sutures
      13.4.3. Vascular Stents
      13.4.4. Vascular Grafts
      13.4.5. Dermal Wound Healing
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Drug Integrated Polymer Fibers Market Size and Volume Forecast by Type
      13.7.1. Polylactic Acid
      13.7.2. Polydioxanone
      13.7.3. Polycaprolactone
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Drug Integrated Polymer Fibers Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Drug Integrated Polymer Fibers Market: Market Share Analysis
   14.2. Drug Integrated Polymer Fibers Distributors and Customers
   14.3. Drug Integrated Polymer Fibers Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. TissueGen
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Micro Engineering Solutions
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Integrated Polymer Solutions
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. COMPANY4
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. COMPANY5
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. COMPANY6
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. COMPANY7
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. COMPANY8
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. COMPANY9
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us